Press Releases

Whole Genome Sequencing for GutFlora Now Available by the GutFlora Omics Platform

Mar 1, 2021, 09:43 AM by
The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.

GutFlora Omics Platform belongs to Creative Proteomics. With more than 10 years of experience in providing advanced multi-omics services, GutFlora Omics Platform offers services and support to customers through comprehensive intestinal flora research solutions. The product manager has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.

 

More than 99% of the bacteria in the intestines are anaerobic bacteria, many of which have not been thoroughly studied because they cannot be cultured outside the host. Because traditional isolation and culture methods limit the research of intestinal flora, microbiome analysis can restore the comprehensive genetic information of intestinal flora, thus providing a convenient, efficient and comprehensive solution. These methods greatly benefit from 16S/18S/ITS amplicon sequencing and shotgun metagenomic sequencing based on next-generation sequencing (NGS) technology, which provides a bright spot for the study of intestinal flora

 

The human gastrointestinal tract is colonized by a large number of microorganisms. These microorganisms form communities of bacteria, viruses and microbial eukaryotes, which are specific to people of different ages, eating habits and health conditions. But many of these microorganisms have not been independently cultivated or thoroughly studied. Whole-genome de novo sequencing means that a new genome can be sequenced without a reference sequence, allowing for complex analysis and intestinal microbial sampling independent of culture.

 

The appearance or over-proliferation of parasitic microbes could also be the unignorable inducement for the breakdown of community stability and the reason for jeopardizing our health, making it pivotal to study certain disease-related microbes and their relationship between human.Unlike approaches that only targeted a limited portion of the genome such as 16S/18S/ITS amplicon sequencing, whole-genome sequencing delivers a comprehensive view of the entire genome, which works as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.

 

In addition to providing a complete set of genome sequencing services, Creative Proteomics also provides other informatics services and customized analysis services. If you feel interested and want to learn more, please visit https://gutfloraomics.creative-proteomics.com/

 

About GutFlora Omics Platform of Creative Proteomics

The GutFlora Omics platform, an important division of Creative Proteomics, is dedicated to solving complex problems in intestinal microbiology research through Multi-Omics Technologies. The GutFlora Omics platform can not only provide customers with multi-omics services and bioinformatics analysis, but also seek solutions based on these technologies on the basis of exploring diseases, drug development and many other aspects.